MacroGenics, Inc. (MGNX)
1.42
+0.02
(+1.43%)
USD |
NASDAQ |
Dec 11, 15:12
MacroGenics EPS Diluted (Quarterly): 0.2658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.82M |
| Revenue (Quarterly) | 72.84M |
| Total Expenses (Quarterly) | 56.02M |
| Enterprise Value | 49.43M |
| Gross Profit Margin (Quarterly) | 81.63% |
| Profit Margin (Quarterly) | 23.09% |
| Earnings Yield | -84.96% |
| Normalized Earnings Yield | -84.96 |